Critical Comparison: Anteris Technologies Global (AVR) and The Competition

Anteris Technologies Global (NASDAQ:AVR) is one of 142 publicly-traded companies in the “MED INSTRUMENTS” industry, but how does it compare to its peers? We will compare Anteris Technologies Global to similar companies based on the strength of its dividends, institutional ownership, profitability, earnings, risk, valuation and analyst recommendations.

Valuation & Earnings

This table compares Anteris Technologies Global and its peers revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Anteris Technologies Global	$2.70 million	-$76.29 million	-3.27
Anteris Technologies Global Competitors	$1.75 billion	$196.07 million	5.03

Anteris Technologies Global’s peers have higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Anteris Technologies Global and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	N/A	N/A	N/A
Anteris Technologies Global Competitors	-182.03%	-90.29%	-20.56%

Institutional & Insider Ownership

54.1% of shares of all “MED INSTRUMENTS” companies are held by institutional investors. 4.0% of Anteris Technologies Global shares are held by insiders. Comparatively, 14.1% of shares of all “MED INSTRUMENTS” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Analyst Ratings

This is a summary of recent recommendations and price targets for Anteris Technologies Global and its peers, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	1	0	4	0	2.60
Anteris Technologies Global Competitors	1180	3807	7144	267	2.52

Anteris Technologies Global presently has a consensus target price of $16.50, suggesting a potential upside of 324.16%. As a group, “MED INSTRUMENTS” companies have a potential upside of 18.77%. Given Anteris Technologies Global’s stronger consensus rating and higher possible upside, research analysts clearly believe Anteris Technologies Global is more favorable than its peers.

Anteris Technologies Global Company Profile

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.